OrIGINaLNI radOVI OrIGINaL arTICLEs Analiza rezultata posthemioterapijske retroperitonealne limfadenektomije kod pacijenata sa intermedijarnim i lošim rizikom neseminomskih tumora testisa
Bosl G, Rj M. Testicular germ-cell cancer. N Engl j Med. 1997;242–53.
2.
Einhorn L, Williams Sd L, Pj. Evolution of optimal duration of chemotherapy of favorable-prognosis disseminated germ cell tumors: a southeastern Cancer study Group protocol. Clin Oncol. 1989;387–91.
3.
Seher H, Bosl G, Geller N, Cirrincone C, Whitmore W, Golbey. Impact of symptomatic interval on prognosis of patients with stage III testicular cancer. Urology. 1983;559–61.
4.
Stoter G. Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer; results from a European Organization for research on Treatment of Cancer Multinstitutional Phase II study. Cancer res. 1987;47–2714.
5.
Mead G. The International Germ Cell Conmsensus Classification; a new prognostic factor-based staging classification for metastatic germ cell tumours. Clin Oncol ( r Coll radiol). 1997;207–9.
6.
Donohue Jp, Einhorn L, Sd W. Cytoreductive surgery for metastatic testis cancer : consideration of timing and extent. Urol. 1980;876–90.
7.
Steyeberg E, Keizer E, Fossa Sd. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. Clin Oncol. 1995;1177–87.
8.
The role of adjunctive post-chemotherapy surgery for nonseminomatous germ-cell tumors; current concept and controversies. semin Oncol. 2002;267–71.
9.
Oldenburg, Gc, Lien H, Nn, Woehre H, Sd F. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residualtumor masses. j Clin Oncol. 2003;3310–7.
10.
Long-term follow-up of cisplatin combination chemotherapy in patients with disseminated non-seminomatous testicular tumors: is a post-chemotherapy retroperitoneal lymphadenectomy needed after complete resection? Eur Urol. 2011;(2):319.
11.
Pfister D, Bush J, Schreder M. Pathohistologic findings in patients with nonseminomatous germ cell tumours who undergo postchemotherapy retroperitoneal lymph node dissection for small tumors. Eur Urol. 2011;(2):319.
12.
Long term outcome after postchemotherapy retroperitoneal lymphadenectomy in patientswith residual teratoma. Eur Urol. 2010;(2):236.
13.
Baniel G, Messemer, Einhorn L. Late relapses of testicular cancer. Clin Oncol. 1995;1179–85.
14.
Late relapses following treatment for nonseminomatous testicular tumors according to single centerbased experience. Eur Urol. 2007;(2):157.
15.
Late relapses of germ testicular tumors: a population based experience over 23 years. Eur Urol Meet. 2007;(5):38.
16.
Pathologic findings and clinical outcome in patients undergoing retroperitoneal lymphadenectomy after multiple chemotherapy regimens for metastatic nonseminomatous testicular tumors. Materia Medica. 2011;(1):195–202.
17.
The impact of extra-retroperitoneal masses in patients with advanced nonseminomatous testicular tumors. Eur Urol. 2010;(6):539.
18.
Bs C. Management of post-chemotherapy extra-retroperitoneal residual masses. World j Urol. 2009;482–92.
19.
Fiyayi K, Tjulandin. Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors, prognostic factors and role of postsurgery chemotherapy-results from an international study group. Clin Oncol. 2001;2647–57.
20.
Predicting recurrence following post-chemotherapy retroperitoneal lymphadenectomy for residual fibrosis and teratoma. Eur Urol. 2010;(6):540.
21.
Parkinson M, Fisher C. Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical research Council Testicular Tumor Working Party. Cancer. 1998;1409–19.
22.
Steyeberg E, Hj K, Zwartendijk. Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis. Br j Cancer. 1993;195–200.
23.
Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymphadenectomy. Eur Urol. 2010;(6):573.
24.
Motyer, Pietro V. Teratoma with malignant transformation: diverse malignant histologies in men with germ cell tumors. Urol. 1998;133–8.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
